Latest news
Acalabrutinib May Offer Durable Results in CLL Treatment - MedscapeMedscape · Fri, 07 Aug 2026 13:09:21 GMTClimb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:19:18 GMTPhase 1 Trial Results Highlight Casdatifan’s Potential in Kidney Cancer - Technology NetworksTechnology Networks · Wed, 29 Jul 2026 16:43:08 GMT